|
Intervention | Outcome | Conclusion | Study design/sample size | Certainty of evidence |
|
Ketamine/propofol admixture vs. nonketamine/propofol admixture | HR 5 min | WMD, 3.36 mmHg (95% CI, −0.88 to 7.60), I2 = 88.6% | Six RCTs (n = 465) 11, 27–31 | Very low due to risk of bias, imprecision, and inconsistency |
HR 10 min | WMD, 0.36 mmHg (95% CI, −2.57 to 3.29), I2 = 69.9% | Three RCTs (n = 244) 11, 27, 29 | Very low due to risk of bias, imprecision, and inconsistency |
SBP 5 min | WMD, 9.67 mmHg (95% CI, 1.48 to 17.86), I2 = 87.2% | Five RCTs (n = 385) 11, 27–28, 30–31 | Low due to risk of bias and inconsistency |
SBP 10 min | WMD, 4.56 mmHg (95% CI, −1.09 to 10.20), I2 = 0.0% | Two RCTs (n = 164) 11, 27 | Low due to risk of bias and imprecision |
DBP 5 min | WMD, 2.18 mmHg (95% CI, −2.82 to 7.19), I2 = 73.1% | Four RCTs (n = 305) 11, 28, 30–31 | Very low due to risk of bias, inconsistency, and imprecision |
DBP 10 min | WMD, 4.80 mmHg (95% CI, 0.24 to 9.36), I2 = N/A | One RCT (n = 84) 11 | Low due to risk of bias and imprecision |
MAP 5 min | WMD, 3.28 mmHg (95% CI, −0.94 to 7.49), I2 = 69.9% | Four RCTs (n = 345) 11, 29–31 | Very low due to risk of bias, imprecision, and inconsistency |
MAP 10 min | WMD, 4.08 mmHg (95% CI, −0.22 to 8.39), I2 = 41.4 | Two RCTs (n = 164) 11, 29 | Low due to risk of bias and imprecision |
|